Mark Shaw

2.1k citations

38 papers · 900 indexed · 1 hit paper · h-index 16

Impact in

Radiation top 5%
- Advanced Radiotherapy Techniques
Pulmonary and Respiratory Medicine top 5%
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment

Papers in ⓘ

Ecological Modeling 4
Pulmonary and Respiratory Medicine 27
- Renal cell carcinoma treatment 10
- Lung Cancer Diagnosis and Treatment 10
- Lung Cancer Treatments and Mutations 7
- Prostate Cancer Treatment and Research 5

Co-authors: Shankar Siva (27 shared papers)Mathias Bressel (18 shared papers)Tomas Kron (15 shared papers)Sarat Chander (16 shared papers)Nathan Lawrentschuk (11 shared papers)Farshad Foroudi (7 shared papers)Declan G. Murphy (9 shared papers)Michael S. Hofman (6 shared papers)
Journals: International Journal of Radiation Oncology*Biology*Physics (6 papers)Journal of Clinical Oncology (3 papers)Radiotherapy and Oncology (2 papers)Journal of Thoracic Oncology (2 papers)Clinical Oncology (2 papers)
Partner nations: Australia United Kingdom New Zealand

In The Last Decade

Mark Shaw

37 papers receiving 886 citations

Hit Papers

align trajectories log scale

Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial 2018 · 222 citations

Peers

Countries citing papers authored by Mark Shaw

Since Specialization

Citations

This map shows the geographic impact of Mark Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shaw more than expected).

Fields of papers citing papers by Mark Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shaw. The network helps show where Mark Shaw may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Shaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Shaw Line = papers co-authored together Mark Shaw links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial European Urology ·Shankar Siva, Mathias Bressel, Declan G. Murphy, Mark Shaw, Sarat Chander, John Violet, Keen Hun Tai, Cristian Udovicich, A. J. Lim, Lisa Selbie, Michael S. Hofman, Tomas Kron, Daniel Moon, Jeremy Goad, Nathan Lawrentschuk, Farshad Foroudi Hit paper breakdown →	2018	222
2	Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial European Urology ·Shankar Siva, Mathias Bressel, Simon Wood, Mark Shaw, Sherene Loi, Shahneen Sandhu, Ben Tran, Arun Azad, Jeremy Lewin, Katharine Cuff, Howard Liu, Daniel Moon, Jeremy Goad, Lih‐Ming Wong, Michael Lim‐Joon, Jennifer Mooi, Sarat Chander, Declan G. Murphy, Nathan Lawrentschuk, David Pryor	2021	84
3	Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial British Journal of Urology ·Shankar Siva, Daniel Pham, Tomas Kron, Mathias Bressel, Jacqueline Lam, T H Tan, Brent Chesson, Mark Shaw, Sarat Chander, Suki Gill, Nicholas R. Brook, Nathan Lawrentschuk, Declan G. Murphy, Farshad Foroudi	2017	84
4	Garden and Landscape-Scale Correlates of Moths of Differing Conservation Status: Significant Effects of Urbanization and Habitat Diversity PLoS ONE ·Adam J. Bates, Jon P. Sadler, Dave Grundy, Norman Lowe, George E. Davis, D. James Baker, Malcolm Bridge, Roger Freestone, David Gardner, Chris Gibson, Robin Hemming, Stephen Howarth, Steve Orridge, Mark Shaw, Tom Tams, Heather A. Young	2014	67
5	Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose–response relationship Radiotherapy and Oncology ·Shankar Siva, Price Jackson, Tomas Kron, Mathias Bressel, Eddie Lau, Michael S. Hofman, Mark Shaw, Sarat Chander, Daniel Pham, Nathan Lawrentschuk, Lih‐Ming Wong, Jeremy Goad, Farshad Foroudi	2016	57
6	Ventilation/Perfusion Positron Emission Tomography—Based Assessment of Radiation Injury to Lung International Journal of Radiation OncologyBiologyPhysics ·Shankar Siva, Nicholas Hardcastle, Tomas Kron, Mathias Bressel, Jason Callahan, Michael MacManus, Mark Shaw, Nikki Plumridge, Rodney J. Hicks, Daniel Steinfort, David Ball, Michael S. Hofman	2015	44
7	A role for artificial night-time lighting in long-term changes in populations of 100 widespread macro-moths in UK and Ireland: a citizen-science study Journal of Insect Conservation ·John Fawcett Wilson, D. James Baker, Janet Cheney, Mike Cook, Martin B. Ellis, Roger Freestone, David Gardner, Graham R. Geen, Robin Hemming, Don Hodgers, Stephen Howarth, Ade Jupp, Norman Lowe, Steve Orridge, Mark Shaw, Bob Smith, Audrey Turner, Heather A. Young	2018	40
8	Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma European Urology Open Science ·Cristian Udovicich, Jason Callahan, Mathias Bressel, Wee Loon Ong, Marlon Perera, Ben Tran, Arun Azad, Shankar Haran, Daniel Moon, Sarat Chander, Mark Shaw, Renu Eapen, Jeremy Goad, Nathan Lawrentschuk, Declan G. Murphy, Michael S. Hofman, Shankar Siva	2022	33
9	Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy Planning Technology in Cancer Research & Treatment ·Shankar Siva, Thomas Devereux, David Ball, Michael MacManus, Nicholas Hardcastle, Tomas Kron, Mathias Bressel, Farshad Foroudi, Nikki Plumridge, Daniel Steinfort, Mark Shaw, Jason Callahan, Rodney J. Hicks, Michael S. Hofman	2015	33
10	Treatment of Brain Metastases in Lung Cancer: Strategies to Avoid/Reduce Late Complications of Whole Brain Radiation Therapy Current Treatment Options in Oncology ·Mark Shaw, David Ball	2013	31
11	Assessing the value of the Garden Moth Scheme citizen science dataset: how does light trap type affect catch? Entomologia Experimentalis et Applicata ·Adam J. Bates, Jon P. Sadler, Glyn Everett, Dave Grundy, Norman Lowe, George E. Davis, D. James Baker, Malcolm Bridge, Jon Clifton, Roger Freestone, David Gardner, Chris Gibson, Robin Hemming, Stephen Howarth, Steve Orridge, Mark Shaw, Tom Tams, Heather A. Young	2013	29
12	MA 13.07 A Randomized Trial of SABR vs Conventional Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: TROG09.02 (CHISEL) Journal of Thoracic Oncology ·Daniel Ball, T. Mai, Shalini Vinod, Scott Babington, Jeremy Ruben, Tomas Kron, Brent Chesson, Alan Herschtal, Angela Rezo, Christine Elder, Marketa Skala, A. Wirth, Greg Wheeler, Andrew Lim, Marijana Vanevski, Mark Shaw	2017	26
13	Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases International Journal of Radiation OncologyBiologyPhysics ·Paolo G. Sogono, Mathias Bressel, Steven David, Mark Shaw, Sarat Chander, Julie Chu, Nikki Plumridge, Keelan Byrne, Nicholas Hardcastle, Tomas Kron, Greg Wheeler, Gerard G. Hanna, Michael MacManus, David Ball, Shankar Siva	2020	25
14	A geographic analysis of the status of mountain lions in Oklahoma SHAREOK (University of Oklahoma) ·Jason R. Pike, J. H. Shaw, David M. Leslie, Mark Shaw	1999	20
15	Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma PLoS ONE ·Hayley M. Reynolds, Bimal Parameswaran, Mary E. Finnegan, Diana Roettger, Eddie Lau, Tomas Kron, Mark Shaw, Sarat Chander, Shankar Siva	2018	16
16	Single Fraction Stereotactic Ablative Body Radiotherapy for Oligometastasis: Outcomes from 132 Consecutive Patients Clinical Oncology ·Senthilkumar Gandhidasan, David Ball, Tomas Kron, Mathias Bressel, Mark Shaw, Julie Chu, Sarat Chander, Greg Wheeler, Nikki Plumridge, Brent Chesson, Steven David, Shankar Siva	2017	16
17	NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy Radiation Oncology ·Nicholas Hardcastle, Michael S. Hofman, Ching‐Yu Lee, Jason Callahan, Lisa Selbie, Farshad Foroudi, Mark Shaw, Sarat Chander, A. J. Lim, Brent Chesson, Declan G. Murphy, Tomas Kron, Shankar Siva	2019	11
18	Stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumors: The RAPPORT trial. Journal of Clinical Oncology ·Shankar Siva, Mathias Bressel, Simon Wood, Mark Shaw, Sherene Loi, Shahneen Sandhu, Ben Tran, Arun Azad, Jeremy Lewin, Katharine Cuff, Nitika Neha, Duncan Colyer, Paul J. Neeson, Howard Liu, Sarat Chander, Daniel Moon, Jeremy Goad, Declan G. Murphy, Nathan Lawrentschuk, David Pryor	2021	8
19	A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol Contemporary Clinical Trials Communications ·David Pryor, Mathias Bressel, Nathan Lawrentschuk, Ben Tran, Jennifer Mooi, Jeremy Lewin, Arun Azad, Duncan Colyer, Nitika Neha, Mark Shaw, Sarat Chander, Paul J. Neeson, Daniel Moon, Katharine Cuff, Simon Wood, Declan G. Murphy, Shahneen Sandhu, Sherene Loi, Shankar Siva	2021	7
20	Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases International Journal of Radiation OncologyBiologyPhysics ·Shankar Siva, Gavin Jones, Mathias Bressel, Mark Shaw, Sarat Chander, Julie Chu, Nikki Plumridge, Keelan Byrne, Gargi Kothari, Nicholas Hardcastle, Mathieu Gaudreault, Tomas Kron, Greg Wheeler, Michael MacManus, Gerard G. Hanna, David Ball, Steven David	2022	7

About Mark Shaw

Mark Shaw is a scholar working on Ecological Modeling, Pulmonary and Respiratory Medicine, Radiation, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 38 papers that have together received 900 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (10 papers), Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (7 papers), Advanced Radiotherapy Techniques (6 papers), Medical Imaging Techniques and Applications (5 papers), Bladder and Urothelial Cancer Treatments (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Prostate Cancer Treatment and Research (5 papers). The work is most often cited by research in Radiation (177 citations), Pulmonary and Respiratory Medicine (599 citations), Radiology, Nuclear Medicine and Imaging (287 citations), Ecological Modeling (48 citations) and Cancer Research (106 citations). Mark Shaw has collaborated with scholars based in Australia, United Kingdom and New Zealand. Frequent co-authors include Shankar Siva, Mathias Bressel, Tomas Kron, Sarat Chander, Nathan Lawrentschuk, Farshad Foroudi, Declan G. Murphy, Michael S. Hofman, David Ball and Jeremy Goad. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Radiotherapy and Oncology, Journal of Thoracic Oncology and Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact